Compare ALEMBIC PHARMA with Suven Life Sciences - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA SUVEN LIFE SCIENCES ALEMBIC PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 17.6 -105.1 - View Chart
P/BV x 7.0 1.6 423.2% View Chart
Dividend Yield % 0.5 1.4 39.2%  

Financials

 ALEMBIC PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
SUVEN LIFE SCIENCES
Mar-19
ALEMBIC PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs664338 196.6%   
Low Rs412169 243.4%   
Sales per share (Unadj.) Rs208.752.1 400.4%  
Earnings per share (Unadj.) Rs31.06.8 453.8%  
Cash flow per share (Unadj.) Rs37.18.6 433.0%  
Dividends per share (Unadj.) Rs5.501.50 366.7%  
Dividend yield (eoy) %1.00.6 172.7%  
Book value per share (Unadj.) Rs144.265.3 220.9%  
Shares outstanding (eoy) m188.52127.28 148.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.64.9 53.0%   
Avg P/E ratio x17.437.1 46.8%  
P/CF ratio (eoy) x14.529.6 49.0%  
Price / Book Value ratio x3.73.9 96.1%  
Dividend payout %17.722.0 80.8%   
Avg Mkt Cap Rs m101,46132,272 314.4%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m7,467661 1,129.3%   
Avg. sales/employee Rs ThNM6,132.2-  
Avg. wages/employee Rs ThNM611.1-  
Avg. net profit/employee Rs ThNM803.5-  
INCOME DATA
Net Sales Rs m39,3476,635 593.0%  
Other income Rs m94242 38.7%   
Total revenues Rs m39,4416,877 573.5%   
Gross profit Rs m8,7361,604 544.6%  
Depreciation Rs m1,152221 520.5%   
Interest Rs m18438 488.3%   
Profit before tax Rs m7,4931,587 472.0%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568718 218.3%   
Profit after tax Rs m5,844869 672.1%  
Gross profit margin %22.224.2 91.8%  
Effective tax rate %20.945.2 46.2%   
Net profit margin %14.913.1 113.3%  
BALANCE SHEET DATA
Current assets Rs m19,5776,232 314.1%   
Current liabilities Rs m14,8961,490 999.7%   
Net working cap to sales %11.971.5 16.6%  
Current ratio x1.34.2 31.4%  
Inventory Days Days9086 103.8%  
Debtors Days Days4583 54.9%  
Net fixed assets Rs m27,0974,043 670.2%   
Share capital Rs m377127 296.2%   
"Free" reserves Rs m26,8118,183 327.7%   
Net worth Rs m27,1888,310 327.2%   
Long term debt Rs m4,99318 28,050.6%   
Total assets Rs m47,77810,389 459.9%  
Interest coverage x41.743.1 96.7%   
Debt to equity ratio x0.20 8,573.5%  
Sales to assets ratio x0.80.6 128.9%   
Return on assets %12.68.7 144.5%  
Return on equity %21.510.5 205.4%  
Return on capital %23.619.5 120.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4535,622 346.0%   
Fx outflow Rs m6,0651,799 337.0%   
Net fx Rs m13,3883,822 350.3%   
CASH FLOW
From Operations Rs m8,120356 2,284.0%  
From Investments Rs m-7,556-279 2,712.1%  
From Financial Activity Rs m590-225 -262.3%  
Net Cashflow Rs m1,153-148 -778.2%  

Share Holding

Indian Promoters % 74.1 63.4 116.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.0 -  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 36.5 38.1%  
Shareholders   49,328 37,287 132.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Apr 22, 2021 03:37 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS